# Sodium Valproate-loaded Nanospanlastics in Patchy Alopecia Areata in Comparison to Topical Steroids

> **NCT05017454** · EARLY_PHASE1 · COMPLETED · sponsor: **Kasr El Aini Hospital** · enrollment: 67 (actual)

## Conditions studied

- Alopecia Areata

## Interventions

- **DRUG:** the optimized sodium valproate-loaded nanospanlastic dispersion
- **DRUG:** mometasone furoate lotion

## Key facts

- **NCT ID:** NCT05017454
- **Lead sponsor:** Kasr El Aini Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-01
- **Primary completion:** 2023-01-01
- **Final completion:** 2023-04-01
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2023-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05017454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05017454, "Sodium Valproate-loaded Nanospanlastics in Patchy Alopecia Areata in Comparison to Topical Steroids". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05017454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*